Login / Signup

Modifier Role of Common RET Variants in Sporadic Medullary Thyroid Carcinoma.

Anna Elżbieta SkalniakMałgorzata Trofimiuk-MüldnerElwira Przybylik-MazurekAlicja Hubalewska-Dydejczyk
Published in: International journal of molecular sciences (2021)
Background: Although the disease-causing effect of pathogenic variants in the gene RET has been unambiguously identified, there is a lack of consensus regarding the possible impact of common variants in this gene. Our study aimed to test whether variants in exons 10, 11, and 13-16 that are commonly detected during routine diagnostic testing might have any modifying effect on MTC. Methods: In sporadic MTC patients with no pathogenic variants but with or without common variants in RET, the following variants were evaluated: rs1799939 (p.G691S), rs1800861 (p.L769=), rs1800862 (p.S836=), rs2472737 in intron 14, and rs1800863 (p.S904=). Results: After Bonferroni correction, none of the variants were statistically significantly associated with disease outcome when analysed independently. The MTC group was divided into three genetically different clusters by unsupervised k-means clustering. Those clusters differed significantly in the age at diagnosis. A trend towards the association of given clusters with metabolic disorders and with remission state was identified. Conclusions: Although common variants in RET are not responsible for the risk of MTC, their analysis might turn out useful in the prediction of a patient's clinical outcome. Importantly, this analysis would come with no additional cost in laboratories with a diagnostic procedure based on exon sequencing.
Keyphrases
  • copy number
  • genome wide
  • late onset
  • gene expression
  • rheumatoid arthritis
  • clinical practice
  • minimally invasive